CompletedNot Applicable

Comparison of Lung Expansion After Uniportal and Multiportal Video Assisted Thoracic Surgery for Stage II Post Pneumonic Bacterial Empyema Thoracis

Pakistan160 participantsStarted 2023-04-01

Plain-language summary

It was a parallel-armed randomized control study in which 160 participants admitted to the Thoracic Surgery Department, Services Hospital, Lahore were included. The participants were divided into two equal groups (80 in each group). Uniportal Group participants underwent uniportal video assisted thoracic surgery (VATS), while multiportal Group participants were treated with multiportal video assisted thoracic surgery(VATS). Simple consecutive sampling was carried out. Expansion of lung was evaluated postoperatively at the 1st, 3rd, 7th and 15th postoperative day by chest radiograph after uniportal and multiportal VATS.

Who can participate

Age range18 Years – 73 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with stage II empyema * More than 18 years old patients deemed fit for intervention. * Both genders * Unintubated patients Exclusion Criteria: * Patients with stages I and III empyema * Patient with TB empyema * Patient with Fungal empyema * Patients unfit for general anesthesia. * Unwilling to participate

What they're measuring

complete lung expansion after decortication

Timeframe: 15 days

Trial details

NCT IDNCT07137507

SponsorUniversity of Health Sciences Lahore

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-31

View on ClinicalTrials.gov More Empyema, Pleural trials